World's Best Scientists 2026 revealed!
Award Badge
Immunology
South Africa
2026
Award Badge
Medicine
South Africa
2023

D-Index & Metrics

Immunology

D-Index
96
Citations
38835
World Ranking
846
National Ranking
3

Medicine

D-Index
98
Citations
39676
World Ranking
8863
National Ranking
17

Research.com Recognitions

  • 2026 - Research.com Immunology in South Africa Leader Award
  • 2025 - Research.com Immunology in South Africa Leader Award
  • 2023 - Research.com Medicine in South Africa Leader Award
  • 2022 - Research.com Medicine in South Africa Leader Award
  • 2019 - Fellow of the Royal Society, United Kingdom
  • 2012 - Member of the National Academy of Medicine (NAM)
  • 2009 - Fellow, The World Academy of Sciences
  • Fellow of the Royal Society of South Africa
  • Member of the Association of American Physicians
  • Fellow of the Royal Society of South Africa
  • Member of the Association of American Physicians
  • Fellow of the Royal Society of South Africa
  • Member of the Association of American Physicians
  • Fellow of the Royal Society of South Africa
  • Member of the Association of American Physicians

Overview

Salim S. Abdool Karim is affiliated with the Centre for the AIDS Programme of Research in South Africa. Their research spans multiple domains within medicine, focusing primarily on infectious diseases and epidemiology. The major fields of study include Medicine and Immunology and Microbiology, with subfields specifically highlighting Infectious Diseases, Virology, Epidemiology, Immunology, and Modeling and Simulation.

The scientist's work addresses several key topics, such as HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, HIV/AIDS Research and Interventions, COVID-19 epidemiological studies, Reproductive tract infections research, COVID-19 Clinical Research Studies, and HIV/AIDS drug development and treatment.

Salim S. Abdool Karim has published extensively in various academic venues. Frequent publication venues include:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet
  • New England Journal of Medicine
  • Nature Communications

Notable recent papers feature:

  • New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications, 2021, New England Journal of Medicine
  • Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization, 2021, Nature
  • The Lancet Commission on lessons for the future from the COVID-19 pandemic, 2022, The Lancet
  • SARS-CoV-2 variants and ending the COVID-19 pandemic, 2021, The Lancet
  • SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Collaborations have been frequent with co-authors including Quarraisha Abdool Karim, Nigel Garrett, Túlio de Oliveira, Penny L. Moore, and Natasha Samsunder.

Recognition for the scientist has included various fellowships and memberships, such as:

  • Fellow of the Royal Society, United Kingdom (2019)
  • Member of the National Academy of Medicine (NAM) (2012)
  • Fellow, The World Academy of Sciences (2009)
  • Fellow of the Royal Society of South Africa
  • Member of the Association of American Physicians

Best Publications

  • Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

    Quarraisha Abdool Karim;Salim S. Abdool Karim;Salim S. Abdool Karim;Salim S. Abdool Karim;Janet A. Frohlich;Anneke C. Grobler

  • Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

    Unknown

  • Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

    Lut Van Damme;Gita Ramjee;Michel Alary;Bea Vuylsteke

  • Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

    Salim S. Abdool Karim;Kogieleum Naidoo;Anneke Grobler;Nesri Padayatchi

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • Health in South Africa: changes and challenges since 2009

    Bongani M. Mayosi;Joy E. Lawn;Ashley. Van Niekerk;Ashley. Van Niekerk;Debbie. Bradshaw

  • HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

    Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn

  • New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.

    Salim S Abdool Karim;Tulio de Oliveira

  • Integration of antiretroviral therapy with tuberculosis treatment

    Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo;Anna Christina. Grobler;Nesri. Padayatchi

  • The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners.

    Mark N. Lurie;Brian G. Williams;Khangelani Zuma;David Mkaya-Mwamburi

  • The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

    Elin S. Gray;Maphuti C. Madiga;Tandile. Hermanus;Penny L. Moore

  • SARS-CoV-2 variants and ending the COVID-19 pandemic.

    Arnaud Fontanet;Arnaud Fontanet;Brigitte Autran;Bruno Lina;Marie Paule Kieny

  • Achieving the health Millennium Development Goals for South Africa: challenges and priorities

    Mickey. Chopra;Mickey. Chopra;Joy E. Lawn;Joy E. Lawn;David. Sanders;Peter. Barron

  • Genital Inflammation and the Risk of HIV Acquisition in Women

    Lindi Masson;Lindi Masson;Jo Ann S. Passmore;Jo Ann S. Passmore;Lenine J. Liebenberg;Lise Werner

  • Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa.

    Mark N. Lurie;Brian G. Williams;Khangelani Zuma;Khangelani Zuma;David Mkaya-Mwamburi

  • Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

    Constantinos Kurt Wibmer;Jinal N Bhiman;Elin S Gray;Nancy Tumba

  • Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

    Nichole R. Klatt;Ryan. Cheu;Kenzie. Birse;Kenzie. Birse;Alexander S. Zevin

  • Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

    Penny L. Moore;Elin S. Gray;C. Kurt Wibmer;C. Kurt Wibmer;Jinal N. Bhiman;Jinal N. Bhiman

  • Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa

    Ming Li;Jesus F. Salazar-Gonzalez;Cynthia A. Derdeyn;Lynn Morris

  • HIV prevention transformed: the new prevention research agenda

    Nancy S. Padian;Nancy S. Padian;Sandra I. McCoy;Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Nina. Hasen

Frequent Co-Authors

Quarraisha Abdool Karim
Quarraisha Abdool Karim Centre for the AIDS Programme of Research in South Africa
Carolyn Williamson
Carolyn Williamson University of Cape Town
Lynn Morris
Lynn Morris University of the Witwatersrand
Penny L. Moore
Penny L. Moore National Health Laboratory Service
Koleka Mlisana
Koleka Mlisana National Health Laboratory Service
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Vivek Naranbhai
Vivek Naranbhai Monash University
Elin S. Gray
Elin S. Gray Edith Cowan University
Jinal N. Bhiman
Jinal N. Bhiman University of the Witwatersrand
Barton F. Haynes
Barton F. Haynes Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, pursuing advanced degrees in nursing can open exciting career opportunities. Many choose to become Nurse Practitioners, specializing in acute care or family practice. To advance in this field, exploring acnp programs offers a pathway to specialize in acute care settings, complementing immunology expertise.

Accelerated paths are also available for those looking to fast-track their careers. Programs like the accelerated fnp track provide a streamlined education for becoming a Family Nurse Practitioner, delivering essential primary care knowledge alongside immunology fundamentals.

For those starting without a nursing background, enrolling in online rn programs for non nurses in florida and similar programs nationwide can build foundational skills to enter the healthcare field and support immunology research or clinical roles.

Understanding potential earnings is also important. Registered nurses with Doctor of Nursing Practice degrees often see higher salaries based on their state, which can be researched through resources like how much do dnp nurses make. This information helps align career goals with financial expectations in immunology-related healthcare roles.

Best Scientists Citing Salim S. Abdool Karim

Trending Scientists

Recently Published Articles